Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Antidepressant Drugs Market 2018: Opportunities and Forecasts to 2023 - Analysis by Drugs Class and Sales Channel - SSRIs Witnessed Growth at a Noteworthy Rate -

Research and Markets
Posted on: 21 Feb 18

The "Global Antidepressant Drugs Market - Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023)" report has been added to's offering.

According to the report, the global antidepressants market is projected to display a robust growth represented by a CAGR of 3.12% during 2018 - 2023.

The report has covered and analysed the potential of Global Antidepressants Drugs Market and provides statistics and information on market size, shares and growth factors. The report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressants drug. Additionally, the report also highlights market entry strategies for various companies across the globe.

The report analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies and others.

The segment of Selective Serotonin Reuptake Inhibitors (SSRIs) drug class witnessed growth at a noteworthy rate over the past few years and in the forecast period on the back of rising awareness related mental disorders, rising healthcare expenditures along with rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs market in 2017. Key factors driving the robust growth rate of North America region include rising healthcare expenditure, addition of new drugs, rising disposable incomes, rising number of hospitals and clinics etc.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Antidepressant Drugs Market Outlook

5. Global Antidepressant Drugs Market: Growth and Forecast

6. Global Antidepressant Drugs Market: By Drugs Class

7. Global Antidepressant Drugs Market: By Sales Channels

8. Global Antidepressant Drugs Market: Pipeline Analysis

9. Global Antidepressant Drugs Market: Regional Analysis

10. Market Dynamics

11. Market Trends

12. Policy and Regulatory Landscape

13. Porter's Five Forces Analysis - Antidepressant Drugs Market

14. SWOT Analysis - Antidepressant Drugs Market

15. Company Profiles

  • Pfizer
  • GlaxoSmithKline
  • Allergan
  • Forest laboratories
  • Takeda
  • Novartis
  • Eli Lilly

For more information about this report visit

View source version on

Business Wire

Last updated on: 21/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.